Gerresheimer AG (ETR:GXI – Get Free Report) traded up 1.7% during trading on Wednesday . The company traded as high as €67.80 ($70.63) and last traded at €67.80 ($70.63). 142,949 shares were traded during mid-day trading, an increase of 1% from the average session volume of 140,925 shares. The stock had previously closed at €66.65 ($69.43).
Gerresheimer Stock Up 1.7 %
The stock has a market cap of $2.34 billion, a PE ratio of 20.42, a P/E/G ratio of 0.82 and a beta of 0.94. The business has a 50 day simple moving average of €71.16 and a 200 day simple moving average of €84.90. The company has a debt-to-equity ratio of 79.36, a current ratio of 0.87 and a quick ratio of 0.40.
Gerresheimer Company Profile
Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services.
See Also
- Five stocks we like better than Gerresheimer
- Overbought Stocks Explained: Should You Trade Them?
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- 3 Fintech Stocks With Good 2021 Prospects
- 3 Steel Stocks Soaring After Tariff Announcements
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.